BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

352 related articles for article (PubMed ID: 31146489)

  • 1. A Four-Pseudogene Classifier Identified by Machine Learning Serves as a Novel Prognostic Marker for Survival of Osteosarcoma.
    Liu F; Xing L; Zhang X; Zhang X
    Genes (Basel); 2019 May; 10(6):. PubMed ID: 31146489
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Application of Machine Learning in Developing a Novelty Five-Pseudogene Signature to Predict Prognosis of Head and Neck Squamous Cell Carcinoma: A New Aspect of "Junk Genes" in Biomedical Practice.
    Xing L; Zhang X; Guo M; Zhang X; Liu F
    DNA Cell Biol; 2020 Apr; 39(4):709-723. PubMed ID: 32045271
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Expression scoring of a small-nucleolar-RNA signature identified by machine learning serves as a prognostic predictor for head and neck cancer.
    Xing L; Zhang X; Zhang X; Tong D
    J Cell Physiol; 2020 Nov; 235(11):8071-8084. PubMed ID: 31943178
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The lncRNAs RP1-261G23.7, RP11-69E11.4 and SATB2-AS1 are a novel clinical signature for predicting recurrent osteosarcoma.
    Ying T; Dong JL; Yuan C; Li P; Guo Q
    Biosci Rep; 2020 Jan; 40(1):. PubMed ID: 31850493
    [TBL] [Abstract][Full Text] [Related]  

  • 5. High levels of long non-coding RNA DICER1-AS1 are associated with poor clinical prognosis in patients with osteosarcoma.
    Hu XH; Dai J; Shang HL; Zhao ZX; Hao YD
    Eur Rev Med Pharmacol Sci; 2018 Nov; 22(22):7640-7645. PubMed ID: 30536305
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A four-methylated LncRNA signature predicts survival of osteosarcoma patients based on machine learning.
    Deng Y; Yuan W; Ren E; Wu Z; Zhang G; Xie Q
    Genomics; 2021 Jan; 113(1 Pt 2):785-794. PubMed ID: 33069828
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Decreased expression of long non-coding RNA MEG3 acts as a potential predictor biomarker in progression and poor prognosis of osteosarcoma.
    Tian ZZ; Guo XJ; Zhao YM; Fang Y
    Int J Clin Exp Pathol; 2015; 8(11):15138-42. PubMed ID: 26823857
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Identification of a 15-pseudogene based prognostic signature for predicting survival and antitumor immune response in breast cancer.
    Tan L; He X; Shen G
    Aging (Albany NY); 2020 Dec; 13(10):14499-14521. PubMed ID: 33378744
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Importance of CD8 Tex cell-associated gene signatures in the prognosis and immunology of osteosarcoma.
    Lu Y; Cao N; Zhao M; Zhang G; Zhang Q; Wang L
    Sci Rep; 2024 Apr; 14(1):9769. PubMed ID: 38684858
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Elevated long noncoding RNA HAGLROS expression correlates with clinical progression and prognosis in osteosarcoma.
    Wu PF; Dai ZT; Liu WD; Zhao ZX; Kong YH
    Eur Rev Med Pharmacol Sci; 2019 Feb; 23(4):1428-1433. PubMed ID: 30840263
    [TBL] [Abstract][Full Text] [Related]  

  • 11. LncRNA FAL1 is a negative prognostic biomarker and exhibits pro-oncogenic function in osteosarcoma.
    Wang Y; Zhao Z; Zhang S; Li Z; Li D; Yang S; Zhang H; Zeng X; Liu J
    J Cell Biochem; 2018 Nov; 119(10):8481-8489. PubMed ID: 29987852
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Upregulation of long non-coding RNA TUG1 correlates with poor prognosis and disease status in osteosarcoma.
    Ma B; Li M; Zhang L; Huang M; Lei JB; Fu GH; Liu CX; Lai QW; Chen QQ; Wang YL
    Tumour Biol; 2016 Apr; 37(4):4445-55. PubMed ID: 26499949
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Down-regulation of microRNA-26a and up-regulation of microRNA-27a contributes to aggressive progression of human osteosarcoma.
    Taheriazam A; Bahador R; Karbasy SH; Jamshidi SM; Torkaman A; Yahaghi E; Shakeri M
    Diagn Pathol; 2015 Sep; 10():166. PubMed ID: 26377680
    [TBL] [Abstract][Full Text] [Related]  

  • 14. High expression of long non-coding RNA XIST in osteosarcoma is associated with cell proliferation and poor prognosis.
    Li GL; Wu YX; Li YM; Li J
    Eur Rev Med Pharmacol Sci; 2017 Jun; 21(12):2829-2834. PubMed ID: 28682435
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Identification of 9-Gene Epithelial-Mesenchymal Transition Related Signature of Osteosarcoma by Integrating Multi Cohorts.
    Yiqi Z; Ziyun L; Qin F; Xingli W; Liyu Y
    Technol Cancer Res Treat; 2020; 19():1533033820980769. PubMed ID: 33308057
    [TBL] [Abstract][Full Text] [Related]  

  • 16. An immune-related pseudogene signature to improve prognosis prediction of endometrial carcinoma patients.
    Tang S; Zhuge Y
    Biomed Eng Online; 2021 Jun; 20(1):64. PubMed ID: 34193185
    [TBL] [Abstract][Full Text] [Related]  

  • 17. 12 Survival-related differentially expressed genes based on the TARGET-osteosarcoma database.
    Rothzerg E; Xu J; Wood D; Kõks S
    Exp Biol Med (Maywood); 2021 Oct; 246(19):2072-2081. PubMed ID: 33926256
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Pseudogene-gene functional networks are prognostic of patient survival in breast cancer.
    Smerekanych S; Johnson TS; Huang K; Zhang Y
    BMC Med Genomics; 2020 Apr; 13(Suppl 5):51. PubMed ID: 32241256
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Long non-coding RNA tumor suppressor candidate 7 functions as a tumor suppressor and inhibits proliferation in osteosarcoma.
    Cong M; Li J; Jing R; Li Z
    Tumour Biol; 2016 Jul; 37(7):9441-50. PubMed ID: 26781978
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A prognostic 3-long noncoding RNA signature for patients with gastric cancer.
    Cheng P
    J Cell Biochem; 2018 Nov; 119(11):9261-9269. PubMed ID: 30074647
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 18.